IN-DATE
RONYX35026UX: Medtronic Resolute Onyx RX Zotarolimus-Eluting Coronary Stent System: 3.5mm x 26mm
Sign in to add this product to your favorites!
| Price: | $649.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Expiration: | 03-2027 |
| Express: | Need it tomorrow? Order in next 2 hours 41 minutes and choose overnight shipping at checkout. |
Related Items
QUICK VIEW
| ONYXNG35026UX - Size: 3.50mm $855.00 per box of 1 Medtronic Onyx Frontier RX Drug-Eluting Coronary Stent System (DES) 3.5mm x 26mm Exp: 09-2026 Units in stock: 1 box of 1 | Order Qty |
|
QUICK VIEW
| ONYXNG35015UX - Size: 3.50mm $855.00 per box of 1 Medtronic Onyx Frontier RX Drug-Eluting Coronary Stent System (DES) 3.5mm x 15mm Exp: 04-2027 Units in stock: 1 box of 1 | Order Qty |
Additional Details
Medtronic Resolute Onyx Drug-Eluting Stent (DES) Coronary Stent System
Resolute Onyx™ Drug-Eluting Stent (DES) features a single wire design, a platinum-iridium core, and a broad diameter range.
- Stent Design: Continuous sinusoid technology with core wire technology
- Polymer and Drug: BioLinx™ polymer and zotarolimus
- Delivery System: Resolute Onyx™ delivery system
- Stent Material: Shell: Cobalt alloy, Core: Pt–Ir
- Base Coating: Parylene C
- Polymer Coating: BioLinx™ polymer
- Drug Density: Zotarolimus (~1.6 μg/mm2)
- Balloon Material: Enhanced Fulcrum™ material
- Catheter Length: 140cm
- Nominal Pressure: 12 atm
- Marker Band Material: Platinum iridium
Additional Details
- Company Name: Medtronic, Inc.
- FDA Product Code: NIQ
- FDA Product Code Name: Coronary Drug-Eluting Stent
- GMDN Term Code: 56284
- GMDN Term Name: Drug-eluting coronary artery stent, non-bioabsorbable-polymer-coated
- GMDN Term Definition: A non-bioabsorbable metal tubular mesh structure covered with a non-bioabsorbable polymer and a drug coating that is designed to be implanted, via a delivery catheter, into a coronary artery (or saphenous vein graft) to maintain its patency typically in a patient with symptomatic atherosclerotic heart disease. The drug coating is slowly released and intended to inhibit restenosis by reducing vessel smooth muscle cell proliferation. Disposable devices associated with implantation may be included.
AccessGUDID Info
- FDA Product Code: NIQ
- FDA Product Code Name: Coronary drug-eluting stent
- GMDN Term Code: 56284
- GMDN Term Name: Drug-eluting coronary artery stent, non-bioabsorbable-polymer-coated
- GMDN Term Description: A non-bioabsorbable metal tubular mesh structure covered with a non-bioabsorbable polymer and a drug coating that is designed to be implanted, via a delivery catheter, into a coronary artery (or saphenous vein graft) to maintain its patency typically in a patient with symptomatic atherosclerotic heart disease. The drug coating is slowly released and intended to inhibit restenosis by reducing vessel smooth muscle cell proliferation. Disposable devices associated with implantation may be included.
Manufacturer
Medtronic Cardiovascular Therapies offers a broad range of solutions for treating peripheral artery disease, aortic aneurysms, deep vein thrombosis, and other vascular conditions. Key technologies include the Endurant II and Endurant IIs stent graft systems for abdominal aortic aneurysms, the IN.PACT Admiral drug-coated balloon for femoropopliteal disease, and the Abre venous self-expanding stent system for iliofemoral venous outflow obstruction. With a commitment to advancing minimally invasive therapies, Medtronic’s vascular innovations help restore blood flow, reduce procedural risk, and improve quality of life for patients with complex vascular disease.
There is no valid manufacturer warranty on the products that Synergy Surgical sells. Any services provided by the original manufacturer of the products we sell are not available. However, eSutures offers a 100% money back guarantee (less shipping) on every item we sell within 30 days of purchase. For details, please see our Return Policy.
